HomeThe enzymeTechnologyIngredientsStudiesAbout

Does inflammation increase MMP13?

Yes, in lab studies. The inflammatory messenger IL-1 raised MMP13 in human cartilage and cartilage cells in several studies, and TNF-alpha did too. To switch the MMP13 gene on, IL-1 needs three signalling routes inside the cell: p38, JNK and NF-kB. Most of this evidence comes from cells in a dish.

The evidence from cartilage cells

Inflammatory messengers, or cytokines, have raised MMP13 in every study here that tested them:

  • IL-1 alpha significantly raised MMP13, at both the gene and protein level, in human cartilage (Mitchell 1996).
  • IL-1 beta and TNF-alpha raised collagenase-3 production by human cartilage cells, depending on time and dose (Reboul 1996).
  • IL-1 beta at 2 ng/ml raised MMP13 secretion by cartilage cells from people with osteoarthritis or rheumatoid arthritis (Julovi 2011).
  • IL-1 beta raised MMP13 and lowered type II collagen in rat cartilage cells (Wang 2017).

How the signal gets through

Mengshol and colleagues worked out the wiring in 2000. IL-1 needed p38 and JNK, two signalling enzymes, and the movement of NF-kB into the cell nucleus, to switch the MMP13 gene on. That meant two control proteins, NF-kB and AP-1, were both required (Mengshol 2000). MMP-1, the older collagenase, was switched on through a different set of routes (Mengshol 2000).

Later studies fit that picture. In human cartilage cells, IL-1 beta raised MMP13 through p38 (Julovi 2011). In rat cartilage cells, IL-1 beta switched on NF-kB, and MMP13 is one of its target genes (Wang 2017).

Tonia Vincent's group has found that abnormal load alone can switch on the same signalling pathways inside joint cells that IL-1 does. She calls it mechanoinflammation.

It's got nothing to do with immune cells. You don't have to have white cells swimming around and getting activated … This is intrinsic to the cells of the joint, so the cells of the cartilage, the cells of the bone, the cells of the synovium.

Tonia Vincent, Professor of Musculoskeletal Biology at the University of Oxford's Kennedy Institute, speaking on Joint Action, 2020

Inflammation and age

Age makes cartilage cells more responsive. Cells from older donors made significantly more MMP13 when provoked with IL-1 beta or matrix protein fragments, and blocking NF-kB stopped the fragments' effect (Forsyth 2005). Older cells also made more IL-1 beta at rest (Forsyth 2005).

Inflammation reaches the cell's clock as well. In Auckland studies, IL-1 beta disturbed the clock genes in human cartilage cells while raising MMP13, and turning down the clock gene PER2 partly reversed it (Rong 2019).

Why so many studies start with IL-1

Because IL-1 reliably raises MMP13, it is the standard way to provoke cartilage cells before testing a compound. The hyaluronan, curcumin and curcumin-with-omega-3 studies on this site all used IL-1 beta (Julovi 2011; Wang 2017; Jhun 2025). The frankincense study used IL-1 alpha with a second cytokine, oncostatin M, to break down cartilage samples over 28 days (Blain 2010). A compound that blunts the IL-1 response in these tests shows a mechanism in cells, not an effect in people.

IL-1 has the same effect on lab-grown cartilage, as F. Guilak's group found while working on living joint replacements.

If we expose our engineered cartilage to even low levels … of interleukin 1, you can see the cells are alive but they make enzymes and stop making cartilage and they just destroy our new cartilage immediately.

F. Guilak, speaking at the Hip Symposium Bern, 2020

Blocking the signal versus blocking the enzyme

There are two places to intervene. One is upstream, calming the signal. Curcumin suppressed NF-kB activation in rat cartilage cells, and MMP13 fell (Wang 2017). Hyaluronan worked through its receptor CD44 to damp p38 and MMP13 in human cartilage cells (Julovi 2011).

The other is the enzyme itself. A curcumin metabolite, curcumin monoglucuronide, bound and blocked MMP13 directly without affecting NF-kB-driven inflammatory genes (Roy 2025).

Other questions people ask

What is IL-1 beta?

A cytokine, a messenger protein released during inflammation. In cartilage cell studies it is the most common trigger used to raise MMP13.

Is MMP13 controlled the same way as MMP-1?

No. IL-1 needs p38, JNK and NF-kB to switch on MMP13, but MMP-1 depends on a different combination of routes.

Can MMP13 be blocked without calming inflammation?

In the lab, yes. A curcumin metabolite blocked the MMP13 enzyme directly without changing NF-kB-driven inflammatory genes.

Sources

  1. Mitchell PG, Magna HA, Reeves LM et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996.
  2. Reboul P, Pelletier JP, Tardif G et al. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest 1996.
  3. Julovi SM, Ito H, Nishitani K et al. Hyaluronan inhibits matrix metalloproteinase-13 in human arthritic chondrocytes via CD44 and P38. J Orthop Res 2011.
  4. Wang J, Ma J, Gu JH et al. Regulation of type II collagen, matrix metalloproteinase-13 and cell proliferation by interleukin-1β is mediated by curcumin via inhibition of NF-κB signaling in rat chondrocytes. Mol Med Rep 2017.
  5. Mengshol JA, Vincenti MP, Coon CI et al. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 2000.
  6. Forsyth CB, Cole A, Murphy G et al. Increased matrix metalloproteinase-13 production with aging by human articular chondrocytes in response to catabolic stimuli. J Gerontol A Biol Sci Med Sci 2005.
  7. Rong J, Zhu M, Munro J et al. Altered expression of the core circadian clock component PERIOD2 contributes to osteoarthritis-like changes in chondrocyte activity. Chronobiol Int 2019.
  8. Jhun J, Lee D, Na HS et al. Curcumin and omega-3 ameliorate experimental osteoarthritis progression in terms of joint pain and mitochondrial dysfunction. J Inflamm (Lond) 2025.
  9. Blain EJ, Ali AY, Duance VC. Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilage. Phytother Res 2010.
  10. Roy HS, Kulkarni C, Neethu KM et al. Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13. Arch Pharm Res 2025.

Read next

Terms on this page

Last reviewed 3 November 2026Every study cited here is indexed on PubMed. How we read the evidence